Dasatinib Tablets
Anticancer Medicine / BCR-ABL Inhibitor
Dasatinib Tablets
Aprazer Healthcare – Leading WHO-GMP certified manufacturer and global exporter of Dasatinib Tablets (Dasakast). High-quality, reliable, affordable medicine.
Formulation
Tablets
Standard
WHO-GMP Certified Quality
Supply Type
Global Export & Institutional Supply
Finished Commercial Brand
Available finished formulation under our brand name DASAKAST 70mg.
View Commercial Product Details
WHO-GMP Certified
Global Export Ready
Quality Assured
Formulation Insights
Comprehensive Medical Overview
Dasatinib Tablets
Classification: Anticancer Medicine / BCR-ABL Inhibitor
About Dasatinib Tablets
Dasatinib is a potent oral tyrosine kinase inhibitor used to treat Philadelphia chromosome-positive chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL).
Dasatinib Tablets (Dasakast) Manufactured by Aprazer Healthcare
Dasakast is formulated and manufactured under strict WHO-GMP compliance, delivering proven bioequivalence, therapeutic efficacy, and clinical reliability globally.